Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,864 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 822
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +21.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (419)

clinicaltrialsPublishedShowing 51–100 of 265 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03025256	Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease	active not recruiting	Phase 1	75	M.D. Anderson Cancer CenterOTHER	1	Aug 19, 2026	clinicaltrials
NCT06108206	Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma	active not recruiting	—	20	Columbia UniversityOTHER	1	Aug 19, 2026	clinicaltrials